Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.

Search TravelDoctorOnline

Authors: Chui MH,
Address: Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada. michaelherman.chui@utoronto.ca
Journal: Int J Cancer.


Publication: 2013 Apr 1;132(7):1487-95. doi: 10.1002/ijc.27745. Epub 2012 Sep 28.

abstract

Epithelial-Mesenchymal Transition (EMT) has been implicated as the critical event initiating cancer invasion and metastasis. After disseminating through the circulation, the malignant cells have been proposed to undergo subsequent mesenchymal-epithelial transition (MET) to form secondary tumors. However, strong evidence from human tumor specimens for this paradigm is lacking. In carcinomas, cancers derived from epithelial tissues, epithelial morphology and gene expression are always retained to some degree. While mesenchymal transdifferentiation may be involved in the pathogenesis of carcinosarcomas, even in these neoplasms, as well as in germ cell tumors capable of multilineage differentiation, the mesenchymal phenotype does not facilitate metastatic progression. Indeed, most cancers invade and travel through lymphatic and blood vessels via cohesive epithelial migration, rather than going through the EMT-MET sequence. EMT gene expression is also consistently associated with high histologic grade and while the transcription factors, Snail, Slug and Twist have traditionally been thought of as inducers of EMT, under certain conditions, they also mediate dedifferentiation and maintenance of the stem cell state. In various malignancies, including basal-like breast cancer and colorectal cancer, the genetically unstable, undifferentiated phenotype predicts early metastatic spread and poor prognosis. This article discusses some of the controversies surrounding differentiation and metastasis from a clinicopathologic perspective and presents evidence that the epithelial phenotype is maintained throughout the process of cancer metastasis.

Copyright © 2012 UICC.



Related Articles
Review Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
J Mammary Gland Biol Neoplasia. 2010
Review Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS, Farabaugh SM, Ford HL. J Mammary Gland Biol Neoplasia. 2010 Jun; 15(2):117-34. Epub 2010 May 19.
Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Int J Cancer. 2011
Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Aokage K, Ishii G, Ohtaki Y, Yamaguchi Y, Hishida T, Yoshida J, Nishimura M, Nagai K, Ochiai A. Int J Cancer. 2011 Apr 1; 128(7):1585-95. Epub 2010 Jun 7.
Review The role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 2007
Review The role of epithelial-mesenchymal transition in cancer pathology.
Guarino M, Rubino B, Ballabio G. Pathology. 2007 Jun; 39(3):305-18.
Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Stem Cells. 2012
Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM. Stem Cells. 2012 Feb; 30(2):292-303.
Review The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Crit Rev Oncog. 2011
Review The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Bonavida B, Baritaki S. Crit Rev Oncog. 2011; 16(3-4):211-26.
Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters.
BMC Cancer. 2013
Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters.
Kroepil F, Fluegen G, Vallböhmer D, Baldus SE, Dizdar L, Raffel AM, Hafner D, Stoecklein NH, Knoefel WT. BMC Cancer. 2013 Mar 22; 13:145. Epub 2013 Mar 22.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.